Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-10T03:48:03.708Z Has data issue: false hasContentIssue false
  • English
  • Français

Pseudoephedrine-induced Hemorrhage Associated with a Cerebral Vascular Malformation

Published online by Cambridge University Press:  02 December 2014

Steven K. Baker ,
Jamie E. Silva ,
Ken K.S. Lam  and
Steven K. Baker
Steven K. Baker
Affiliation:
Department of Neurology, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada
Jamie E. Silva
Affiliation:
Department of Neurology, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada
Ken K.S. Lam
Affiliation:
Department of Neurology, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada
Steven K. Baker
Affiliation:
Department of Neurology, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Sympathomimetic-related intracerebral hemorrhage is well-documented. Most cases are associated with phenylpropanolamine use.

Case Report:

We report a case of intracerebral hemorrhage occurring in a middle-aged man who suffered from chronic sinusitis and had been ingesting pseudoephedrine daily for one year. This patient was previously well with no known cardiovascular risk factors. Clinical examination revealed no evidence of vasculitis nor coagulopathy and initial neuroimaging (i.e., computed tomography, angiography, magnetic resonance imaging) demonstrated no features consistent with aneurysm, arteriovenous malformation (AVM), cavernoma, nor cerebral metastases. A follow-up cerebral angiogram demonstrated a small AVM arising off a branch of the pericallosal artery and a small arteriovenous fistula arising off the costal marginal branch. The AVM was embolized without incident, however, the AVF was not accessible.

Conclusions:

Sympathomimetics have long been associated with intracerebral hemorrhage. Since 1979, over 30 published case reports have documented the relationship between phenylpropanolamine and stroke. Only one report links phenylpropanolamine consumption to an intracerebral hemorrhage in a patient with an AVM. There is a paucity of literature etiologically inculpating other ephedra alkaloids in the causation of intracerebral hemorrhage. This is a case of pseudoephedrine-induced intracerebral hemorrhage in a patient with an underlying vascular malformation.

Résumé:

RÉSUMÉ:Introduction:

L’hémorragie intracérébrale (HIC) en relation avec les substances sympathomimétiques est bien connue. La plupart des cas sont associés à la phénylpropanolamine.

Cas clinique:

Il s’agit d’un cas de HIC chez un homme d’âge moyen atteint de sinusite chronique qui faisait usage de pseudoéphédrine quotidiennement depuis un an. Ce patient était en bonne santé, sans facteur de risque cardiovasculaire connu. L’examen clinique n’a montré aucun signe de vasculite ou de coagulopathie. À la neuroimagerie (CT, angiographie, RMN), aucune image compatible avec un anévrisme, une malformation artérioveineuse (MAV), un angiome caverneux ou des metastases cérébrales n’a été décelée. Au cours du suivi, une angiographie cérébrale a montré la présence d’une petite MAV issue d’une branche de l’artère péricalleuse ainsi qu’une petite fistule artérioveineuse (FAV) issue d’une branche de l’artère callosomarginale. La MAV a été traitée par embolisation sans incident. Cependant, la FAV n’était pas accessible.

Conclusions:

Le lien entre les agents sympathomimétiques et l’hémorragie intracérébrale est bien connu. Depuis 1979, plus de 30 cas où il existait une relation entre la phénylpropanolamine et l’accident vasculaire cerebral ont été publiés. On a fait un lien dans un seul cas entre l’utilisation de phénylpropanolamine et l’hémorragie intracérébrale chez un patient ayant une MAV. Il existe peu de publications établissant un lien étiologique entre l’hémorragie intracérébrale et d’autres alcaloïdes de l’éphédra. Ce cas est donc le premier cas d’hémorragie intracérébrale induite par la pseudoéphédrine chez un patient porteur d’une malformation vasculaire.

Type
Case Reports
Information
Canadian Journal of Neurological Sciences , Volume 32 , Issue 2 , May 2005 , pp. 248 - 252
Copyright
Copyright © The Canadian Journal of Neurological 2005

References

1. Lake, CR, Gallant, S, Masson, E, Miller, P. Adverse drug effect sattributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990; 89: 195–208.Google Scholar
2. Glick, R, Hoying, J, Cerullo, L, Perlman, S. Phenylpropanolamine: anover-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery 1987; 20: 969–974.Google Scholar
3. Kase, CS, Foster, TE, Reed, JE, Spatz, EL, Girgis, GN. Intracerebral hemorrhage and phenylpropanolamine use. Neurology 1987; 37: 399–404.Google Scholar
4. Mueller, SM, Muller, J, Asdell, SM. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine. Stroke 1984; 15: 119–123.CrossRefGoogle ScholarPubMed
5. Johnson, DA, Etter, HS, Reeves, DM. Stroke and phenylpropanolamine use. Lancet 1983; 2: 970.Google Scholar
6. King, J. Hypertension and cerebral haemorrhage after trimoletsingestion. Med J Aust 1979; 2: 258.Google Scholar
7. Kikta, DG, Devereaux, MW, Chandar, K. Intracranial hemorrhagesdue to phenylpropanolamine. Stroke 1985; 16: 510–512.Google Scholar
8. Fallis, RJ, Fisher, M. Cerebral vasculitis and hemorrhage associatedwith phenylpropanolamine. Neurology 1985; 35: 405–407.Google Scholar
9. McDowell, JR, LeBlanc, HJ. Phenylpropanolamine and cerebralhemorrhage. West J Med 1985; 142: 688–691.Google Scholar
10. Maher, LM, Peterson, PL, Dela-Cruz, C. Postpartum intracranialhemorrhage and phenylpropanolamine use. Neurology 1987; 37: 1686 Google Scholar
11. Stoessl, AJ, Young, GB, Feasby, TE. Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics. Stroke 1985; 16: 734–736.CrossRefGoogle ScholarPubMed
12. Chung, YT, Hung, DZ, Hsu, CP, Yang, DY, Wu, TC. Intracerebralhemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1998; 61: 432–435.Google Scholar
13. Hamilton, RS, Sharieff, G. Phenylpropanolamine-associatedintracranial hemorrhage in an infant. Am J Emerg Med 2000; 18: 343–345.Google Scholar
14. Maertens, P, Lum, G, Williams, JP, White, J. Intracranial hemorrhageand cerebral angiopathic changes in a suicidal phenylpropanolamine poisoning. South Med J 1987; 80: 1584–1586.Google Scholar
15. Veyrac, G, Huguenin, H, Guillon, B, et al. [Cerebral meningealhemorrhage and acute cerebral angiopathy associated with the taking of phenylpropanolamine: a new case]. Therapie 2001; 56: 323–327.Google Scholar
16. Kizer, KW. Intracranial hemorrhage associated with overdose of decongestant containing phenylpropanolamine. Am J Emerg Med 1984; 2: 180–181.CrossRefGoogle ScholarPubMed
17. Kernan, WN, Viscoli, CM, Brass, LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000; 343: 1826–1832.CrossRefGoogle ScholarPubMed
18. Bruno, A, Nolte, KB, Chapin, J. Stroke associated with ephedrine use. Neurology 1993; 43: 1313–1316.CrossRefGoogle ScholarPubMed
19. Anonymous. Adverse events associated with ephedrine-containingproducts-Texas, December 1993-September 1995. MMWR Morb Mortal Wkly Rep 1996; 45: 689–693.Google Scholar
20. Haller, CA, Benowitz, NL. Adverse cardiovascular and central nervoussystem events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833–1838.Google Scholar
21. Dowd, J, Bailey, D, Moussa, K, et al. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol 1999; 94: 2430–2434.Google Scholar
22. Kanfer, I, Dowse, R, Vuma, V. Pharmacokinetics of oraldecongestants. Pharmacotherapy 1993; 13: 116S–128S.Google Scholar
23. Ryu, SJ, Lin, SK. Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case. J Formos Med Assoc 1995; 94: 53–55.Google Scholar
24. Forman, HP, Levin, S, Stewart, B, Patel, M, Feinstein, S. Cerebralvasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics 1989; 83: 737–741.Google Scholar
25. Bloomfield, EL, Porembka, DT, Ebrahim, ZY, et al. Analysis ofcatecholamine and vasoactive peptide release in intracranial arterial venous malformations. J Neurosurg Anesthesiol 1996; 8: 101–110.Google Scholar
26. Drew, CD, Knight, GT, Hughes, DT, Bush, M. Comparison of theeffects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. Br J Clin Pharmacol 1978; 6: 221–225.Google Scholar
27. Nataf, F, Meder, JF, Ghossoub, M, Merienne, L. [Hemorrhage inarteriovenous malformations: clinical and anatomic data]. Neurochirurgie 2001; 47: 158–167.Google Scholar
28. Tanaka, R, Miyasaka, Y, Fujii, K, Kan, S, Yagishita, S. Vascular structure of arteriovenous malformations. J Clin Neurosci 2000; 7: 24–28.Google Scholar
29. Fleetwood, IG, Steinberg, GK. Arteriovenous malformations. Lancet 2002; 359: 863–873.Google Scholar
30. Ondra, SL, Troupp, H, George, ED, Schwab, K. The natural history ofsymptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990; 73: 387–391.Google Scholar
31. Mast, H, Mohr, JP, Osipov, A, et al. “Steal” is an unestablishedmechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke 1995; 26: 1215–1220.Google Scholar
32. McCormick, WF. Classification, pathology, and natural history of angiomas of the central nervous system. Wkly Update NeurolNeurosurg 1978; 14: 2–7.Google Scholar
33. Kader, A, Young, WL, Pile-Spellman, J, et al. The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1994; 34: 801–807.Google ScholarPubMed
34. Marks, MP, Lane, B, Steinberg, GK, Chang, PJ. Hemorrhage inintracerebral arteriovenous malformations: angiographic determinants. Radiology 1990; 176: 807–813.Google Scholar
35. Cantu, C, Arauz, A, Murillo-Bonilla, LM, Lopez, M, Baringagarrementeria, F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke 2003 34: 1667–1673.Google Scholar